Results 11 to 20 of about 1,368 (214)

Proton pump inhibitor deprescription: A rapid review [PDF]

Brazilian Journal of Pharmaceutical Sciences, 2022
Proton pump inhibitors (PPI) are drugs that suppress gastric acid secretion. Its use, without support from scientific evidence, can contribute to polypharmacy, lead to drug interactions and, in the long term, cause serious adverse reactions.
Renata Rodriguez Imparato, Tereza Setsuko Toma   +1 more
core   +5 more sources

Understanding Medicine Preferences of Older Adults: The Role of Messaging in a Multi‐Methods Experimental Survey

Health Expectations
Background Efforts to optimise medicine use often focus on starting evidence‐based therapies or deprescribing inappropriate medicine, but not on the combination of both. We explored whether behavioural science‐informed messaging could impact older adults'
Alexander Chaitoff, Kristie Rebecca Weir, Vincent D. Marshall, Sarah E. Vordenberg   +3 more
doaj   +2 more sources

Polifarmacia y deprescripción en personas mayores

Revista Médica Clínica Las Condes, 2020
Resumen: De acuerdo a las estimaciones mundiales, el año 2050, habrá más de 2000 millones de personas mayores (PM) de 60 años. En Chile, la situación no es distinta, el país está envejeciendo y esta situación nos expone a nuevos desafíos.
Leonardo Arriagada, Tamara Carrasco, Mikol Araya   +2 more
doaj   +4 more sources

Internet and telephone intervention to support patients discontinuing long-term antidepressants in primary care: the REDUCE research programme including RCT

Programme Grants for Applied Research
Background There is significant concern about increasing long-term antidepressant use in Western countries, much of which is not evidence-based. Median duration of treatment is more than 2 years in the United Kingdom, and more than 10% of adults are ...
Tony Kendrick, Beth Stuart, Hannah Bowers, Mahboobeh Haji Sadeghi, Helen Page, Christopher Dowrick, Michael Moore, Mark Gabbay, Geraldine Leydon, Guiqing Lily Yao, Shihua Zhu, Paul Little, Gareth Griffiths, Glyn Lewis, Carl May, Joanna Moncrieff, Chris F Johnson, Una Macleod, Simon Gilbody, Rachel Dewar-Haggart, Samantha Williams, Wendy O’Brien, Riya Tiwari, Catherine Woods, Tasneem Patel, Naila Khan, Emma Maund, Nadja van Ginneken, Amy Din, Claire Reidy, Rebecca Lucier, Bryan Palmer, Taeko Becque, Yumna Masood, Natalie Thompson, Ellen van Leeuwen, Marta Glowacka, Adam WA Geraghty   +37 more
doaj   +2 more sources

Medical practitioners’ experiences and considerations when managing sleep medication for adolescents and young adults [PDF]

Scandinavian Journal of Primary Health Care
Introduction The prevalence of sleep disorders and use of sleep medication, particularly melatonin, are rising among adolescents and young adults (13–24 years).
Nanna Maria Andersen, Ásthildur Árnadóttir, Tora Grauers Willadsen, Gritt Overbeck   +3 more
doaj   +2 more sources

Tailoring a complex intervention to reduce antidepressants in institutionalized older persons with dementia [PDF]

BMC Health Services Research, 2022
Introduction First-line treatment for behavioral and psychiatric symptoms of dementia is non-pharmacological. Still, psychotropic medication is widely used, despite its limited effect and harmful side-effects. More than half of all nursing home residents
Pernille Hølmkjær, Charlotte Vermehren, Anne Holm, Maarten Pieter Rozing, Kirsten Høj, Gritt Overbeck   +5 more
doaj   +3 more sources

Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey [PDF]

BMC Geriatrics
Background Psychoactive drugs represent a major contributor to falls in older people. This study aims to evaluate the prescribing practice of psychoactive drugs in older people hospitalized for hip fracture (HF) and to explore independent correlates of ...
Andrea Cavalli, Antonio De Vincentis, Claudio Pedone, Alice Laudisio, Lucrezia Santoro, Maria Cristina Ferrara, Caterina Trevisan, Elena Tassistro, Maria Grazia Valsecchi, Giuseppe Castoldi, Chiara Mussi, Giuseppe Sergi, Andrea Ungar, Stefano Volpato, Rocco Papalia, Raffaele Antonelli Incalzi, Giuseppe Bellelli   +16 more
doaj   +2 more sources

Barriers and enablers to opioid deprescription: A qualitative study

PLOS ONE
Background Canada has the fourth highest per capita rate of opioid prescriptions in the world, contributing to the country’s opioid crisis. Due to both their pain-relieving and euphoric properties, opioids can be highly addictive, leading to potential ...
Rebecca Lawrence, Everett Versteeg, Andrea Pike, Holly Etchegary, Amanda Hall   +4 more
semanticscholar   +5 more sources

“Put Me in, Coach”: A Discussion of Deprescribing Roles, Responsibilities, and Motivations Based on a Qualitative Study with Healthcare Professional Students [PDF]

Pharmacy
As the US population ages, the number of prescriptions managed by patients and healthcare teams is increasing. Thus, discontinuing or reducing medications that are considered to pose more risks than benefits can be achieved through deprescribing. Despite
Devin Scott, Amy Hall, Rachel Barenie, Crystal Walker, Muneeza Khan, Paul Koltnow, William R. Callahan, Alina Cernasev   +7 more
doaj   +2 more sources

Why Deprescribing Instead of Not Prescribing? [PDF]

Geriatrics, Gerontology and Aging
Prescribing medications involves complex cognitive processes, and mistakes in prescription can cause serious adverse events. Deprescribing is one of the last opportunities to prevent patient harm from the use of drugs that should be avoided, especially ...
Welma Wildes Amorim, Luiz Carlos Passos, Marcio Galvão Oliveira   +2 more
doaj   +3 more sources